Literature DB >> 28169090

Peripartum Cardiomyopathy Characteristics and Outcomes in Canadian Aboriginal and Non-Aboriginal Women.

Shuangbo Liu1, Sobia A Zuberi2, Amrit A Malik1, Brett M Hiebert1, Allan Schaffer1, Shelley Zieroth1, Francisco J Cordova3.   

Abstract

BACKGROUND: Peripartum cardiomyopathy (PPCM) is a heterogeneous condition characterized by heart failure and left ventricular dysfunction (left ventricular ejection fraction [LVEF] < 45%) in the absence of an alternative cause and a previous diagnosis of cardiomyopathy. The Aboriginal population (Inuit, First Nations, Metis) of Canada often has barriers to health care, which can lead to delays in diagnosis and treatment. Our objectives are to describe PPCM in a Canadian population, and to determine if Canadian Aboriginal women have worse clinical outcomes than non-Aboriginal women.
METHODS: A retrospective study was performed at a single tertiary care centre, between 2008 and 2014. Demographic characteristics, symptoms at presentation, medical history, discharge medications, blood work, echocardiographic parameters, and follow-up information were collected.
RESULTS: A total of 177 women were screened, and 23 were included in the study (52% were Aboriginal). Aboriginal women were found to have higher rates of gravidity and parity, and higher incidence of tobacco smoking than non-Aboriginal women, and were more likely to be discharged with diuretic medications. At diagnosis, Aboriginal women were more likely to have a lower LVEF (20% [interquartile range (IQR), 15%-23%] vs 40% [IQR, 30%-42%]; P = 0.02) and a more dilated left ventricle (left ventricular end-diastolic diameter, 64 mm [IQR, 57-74 mm] vs 54 mm [IQR, 50-57mm]; P < 0.01). Recovery rate, defined as LVEF > 50%, was similar (46% in Aboriginal patients and 60% in non-Aboriginal patients).
CONCLUSIONS: Our findings support that Aboriginal women with PPCM are more likely to present with lower LVEF and a more dilated left ventricle, as well, require more symptomatic management. To our knowledge, this is the first description and contrast of PPCM between Aboriginal and non-Aboriginal Canadians.
Copyright © 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 28169090     DOI: 10.1016/j.cjca.2016.11.001

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  4 in total

1.  Peripartum cardiomyopathy.

Authors:  Hilary Bews; Mahwash Saeed; Shuangbo Liu
Journal:  CMAJ       Date:  2021-11-15       Impact factor: 8.262

2. 

Authors:  Hilary Bews; Mahwash Saeed; Shuanvgbo Liu
Journal:  CMAJ       Date:  2022-01-10       Impact factor: 8.262

Review 3.  The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women - Chapter 5: Sex- and Gender-Unique Manifestations of Cardiovascular Disease.

Authors:  Christine Pacheco; Kerri-Anne Mullen; Thais Coutinho; Shahin Jaffer; Monica Parry; Harriette G C Van Spall; Marie-Annick Clavel; Jodi D Edwards; Tara Sedlak; Colleen M Norris; Abida Dhukai; Jasmine Grewal; Sharon L Mulvagh
Journal:  CJC Open       Date:  2021-11-23

4.  Heart failure in pregnancy: what is the long-term impact of pregnancy on cardiac function? A tertiary care centre experience and systematic review.

Authors:  Anudeep K Dodeja; Francesca Siegel; Katherine Dodd; Marwan Ma'ayeh; Laxmi S Mehta; Margaret M Fuchs; Kara M Rood; May Ling Mah; Elisa A Bradley
Journal:  Open Heart       Date:  2021-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.